Marieta Costache

Papers

Total Citations

H-Index

About

Dr. Marieta Costache is a pioneering researcher at the intersection of oncology and computational diagnostics, whose work is redefining early cancer detection. Her primary research focuses on colorectal cancer (CRC) screening, liquid biopsy technologies, and the integration of artificial intelligence into clinical pathology. In her landmark 2022 study, "Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies," which has garnered 64 citations, Dr. Costache demonstrated how combining circulating tumor biomarkers with machine learning algorithms can dramatically improve patient stratification. Her major contribution lies in proving that AI-enhanced liquid biopsies can detect CRC signatures at earlier, more treatable stages—addressing the critical challenge that CRC prognosis remains tightly linked to stage at diagnosis. This work bridges the gap between molecular biology and data science, offering a non-invasive, scalable solution for population-wide screening. Dr. Costache’s research has profound implications for reducing CRC mortality through earlier intervention, and her innovative approach positions her as a leading voice in the movement toward precision oncology and AI-driven diagnostics.